Thomas Stephan
Stock Analyst at Stifel
(1.48)
# 3,386
Out of 4,944 analysts
45
Total ratings
37.93%
Success rate
-7.62%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Thomas Stephan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STAA STAAR Surgical Company | Downgrades: Hold | $20 → $28 | $28.21 | -0.74% | 10 | Aug 7, 2025 | |
| GKOS Glaukos | Maintains: Buy | $140 → $115 | $91.79 | +25.29% | 9 | May 1, 2025 | |
| RXST RxSight | Maintains: Hold | $33 → $28 | $8.31 | +236.94% | 10 | Mar 19, 2025 | |
| SGHT Sight Sciences | Maintains: Buy | $5 → $4 | $4.25 | -5.88% | 7 | Mar 6, 2025 | |
| BLCO Bausch + Lomb | Maintains: Hold | $19 → $18 | $14.17 | +27.03% | 3 | Jan 29, 2025 | |
| IRIX IRIDEX | Maintains: Hold | $2 | $1.18 | +69.49% | 2 | May 15, 2024 | |
| ALC Alcon | Reiterates: Buy | $95 → $100 | $86.48 | +15.63% | 4 | May 15, 2024 |
STAAR Surgical Company
Aug 7, 2025
Downgrades: Hold
Price Target: $20 → $28
Current: $28.21
Upside: -0.74%
Glaukos
May 1, 2025
Maintains: Buy
Price Target: $140 → $115
Current: $91.79
Upside: +25.29%
RxSight
Mar 19, 2025
Maintains: Hold
Price Target: $33 → $28
Current: $8.31
Upside: +236.94%
Sight Sciences
Mar 6, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $4.25
Upside: -5.88%
Bausch + Lomb
Jan 29, 2025
Maintains: Hold
Price Target: $19 → $18
Current: $14.17
Upside: +27.03%
IRIDEX
May 15, 2024
Maintains: Hold
Price Target: $2
Current: $1.18
Upside: +69.49%
Alcon
May 15, 2024
Reiterates: Buy
Price Target: $95 → $100
Current: $86.48
Upside: +15.63%